Cite

HARVARD Citation

    Rivera, L. et al. (2022). Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003). Clinical infectious diseases. pp. 107-117. [Online]. 
  
Back to record